Cargando…

What Left for Us for Urinary Tract Infection Treatment? An Experience from the South of Iran

BACKGROUND: The aim of the study is to define the prevalence and antimicrobial susceptibility pattern of bacteria from cases of urinary tract infections (UTIs). MATERIALS AND METHODS: A retrospective analysis of urinary pathogens and their antimicrobial susceptibility was done on urine cultures at S...

Descripción completa

Detalles Bibliográficos
Autores principales: Mahmoudi, Ali, Moghadami, Mohsen, Shirazi, Babak, Tabari, Parinaz, Moosavi, Mahsa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8781903/
https://www.ncbi.nlm.nih.gov/pubmed/35127579
http://dx.doi.org/10.4103/abr.abr_255_19
_version_ 1784638192117350400
author Mahmoudi, Ali
Moghadami, Mohsen
Shirazi, Babak
Tabari, Parinaz
Moosavi, Mahsa
author_facet Mahmoudi, Ali
Moghadami, Mohsen
Shirazi, Babak
Tabari, Parinaz
Moosavi, Mahsa
author_sort Mahmoudi, Ali
collection PubMed
description BACKGROUND: The aim of the study is to define the prevalence and antimicrobial susceptibility pattern of bacteria from cases of urinary tract infections (UTIs). MATERIALS AND METHODS: A retrospective analysis of urinary pathogens and their antimicrobial susceptibility was done on urine cultures at Shiraz University Laboratory from 2015 to 2017. Antimicrobial susceptibility tests have done using the disk-diffusion technique as per the standard of CSLI. RESULTS: During 2 years of study, 3489 samples were culture positive. Escherichia coli was the dominant isolate (84%), followed by Klebsiella spp. (10.7%) and Enterococci spp. (2,2%). The overall resistance rates to trimethoprim-sulfamethoxazole, ceftriaxone, and ciprofloxacin were 56.1%, 47.2%, and 37%, respectively. The most frequently isolated bacteria were E. coli, which had resistance rates of 58.6%, 49.1% to TMP-STX, and cefixime, also sensitivity rates of 95.1% to nitrofurantoin (FM). CONCLUSIONS: In the study area, resistance rates to fluoroquinolones and cephalosporins were high. Because most isolates were sensitive to FM and aminoglycoside, they are suggested as appropriate antimicrobials for empirical treatment of UTIs before available urine culture results.
format Online
Article
Text
id pubmed-8781903
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Wolters Kluwer - Medknow
record_format MEDLINE/PubMed
spelling pubmed-87819032022-02-04 What Left for Us for Urinary Tract Infection Treatment? An Experience from the South of Iran Mahmoudi, Ali Moghadami, Mohsen Shirazi, Babak Tabari, Parinaz Moosavi, Mahsa Adv Biomed Res Original Article BACKGROUND: The aim of the study is to define the prevalence and antimicrobial susceptibility pattern of bacteria from cases of urinary tract infections (UTIs). MATERIALS AND METHODS: A retrospective analysis of urinary pathogens and their antimicrobial susceptibility was done on urine cultures at Shiraz University Laboratory from 2015 to 2017. Antimicrobial susceptibility tests have done using the disk-diffusion technique as per the standard of CSLI. RESULTS: During 2 years of study, 3489 samples were culture positive. Escherichia coli was the dominant isolate (84%), followed by Klebsiella spp. (10.7%) and Enterococci spp. (2,2%). The overall resistance rates to trimethoprim-sulfamethoxazole, ceftriaxone, and ciprofloxacin were 56.1%, 47.2%, and 37%, respectively. The most frequently isolated bacteria were E. coli, which had resistance rates of 58.6%, 49.1% to TMP-STX, and cefixime, also sensitivity rates of 95.1% to nitrofurantoin (FM). CONCLUSIONS: In the study area, resistance rates to fluoroquinolones and cephalosporins were high. Because most isolates were sensitive to FM and aminoglycoside, they are suggested as appropriate antimicrobials for empirical treatment of UTIs before available urine culture results. Wolters Kluwer - Medknow 2021-12-25 /pmc/articles/PMC8781903/ /pubmed/35127579 http://dx.doi.org/10.4103/abr.abr_255_19 Text en Copyright: © 2021 Advanced Biomedical Research https://creativecommons.org/licenses/by-nc-sa/4.0/This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
spellingShingle Original Article
Mahmoudi, Ali
Moghadami, Mohsen
Shirazi, Babak
Tabari, Parinaz
Moosavi, Mahsa
What Left for Us for Urinary Tract Infection Treatment? An Experience from the South of Iran
title What Left for Us for Urinary Tract Infection Treatment? An Experience from the South of Iran
title_full What Left for Us for Urinary Tract Infection Treatment? An Experience from the South of Iran
title_fullStr What Left for Us for Urinary Tract Infection Treatment? An Experience from the South of Iran
title_full_unstemmed What Left for Us for Urinary Tract Infection Treatment? An Experience from the South of Iran
title_short What Left for Us for Urinary Tract Infection Treatment? An Experience from the South of Iran
title_sort what left for us for urinary tract infection treatment? an experience from the south of iran
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8781903/
https://www.ncbi.nlm.nih.gov/pubmed/35127579
http://dx.doi.org/10.4103/abr.abr_255_19
work_keys_str_mv AT mahmoudiali whatleftforusforurinarytractinfectiontreatmentanexperiencefromthesouthofiran
AT moghadamimohsen whatleftforusforurinarytractinfectiontreatmentanexperiencefromthesouthofiran
AT shirazibabak whatleftforusforurinarytractinfectiontreatmentanexperiencefromthesouthofiran
AT tabariparinaz whatleftforusforurinarytractinfectiontreatmentanexperiencefromthesouthofiran
AT moosavimahsa whatleftforusforurinarytractinfectiontreatmentanexperiencefromthesouthofiran